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The combined resection with involved lung for esophageal 
carcinoma was evaluated in terms of surgical indication 
and outcome in the 6 patients who underwent subtotal 
esophagectomy with pulmonary resection. It was con-
firmed that the operation was technically feasible but the 
surgical results were unsatisfactory. It was reasoned that 
grave surgical insult and adjuvant therapy to prevent recur-
rence result in immunodepressive status of the host and 
tends to accompany postoperative complications related to 
operative death. 
  In conclusion, prevention of immunosuppression for the 
host is required by meticulous cares of nutrition and elimi-
nation of surgical stress by staged operation in order to 
obtain satisfactory result after surgery.
Introduction 
The surgical outcomes of esophageal carcinomas were 
unsatisfactory even though their pathogenesis and etiology 
had been elucidated. The reason is attributable to far ad-
vanced extension of carcinoma on the basis of anatomical 
specificity of the esophagus which is adjacent to the organs 
surrounding the loose tissue and devoid of the serosal 
layer, probably playing a role in the barrier of extension of 
cancer infiltration. 
 In advanced esophageal carinomas, it is not infrequently 
encountered that cancer infiltration extends outside the wall 
of the esophagus and involves the neighbouring organs. At
that time, surgeons attempt to perform a combined resec-
tion with involved organs in an effort to accomplish opera-
tive radicality despite grave insult surgery. 
 The combined resection with involved organ should be 
striven for establishment of surgical safety in terms of 
immunodepression of the patient by surgical stress, deter-
mination of surgical indication for the poor risk patients 
and prevention of surgical complications related to opera-
tive death. 
 The aim of this study is to clarify the validity of the 
combined resection of the esophageal lesion with the in-
volved lung on the basis of the result of our clinical 
experience.
Patients 
Six patients were eligible to this study (Table 1). They 
underwent the combined resection of the esophagus with 
the lung for thoracic esophageal carcinomas. 
 The ages ranged from 56 to 72 with an average of 63.2 
years The ratio of men to women was equivalent. The 
histologic type was squamous cell carcinoma in all. The 
tumor locations were Im in 3, Im + lu in 2 and Im + Ei in 
one, respectively. 
 The length of shadow defect varied from 4.5cm to 
11.0cm. The histologic findings of resected lungs were 
graded as the following categories (Fig. 1, 2, 3), Grade 0: 
no evidence of histologic cancer invasion to the lung with
Table 1. Patient Profile
   Age Reconstruction Pulmonary resection Shadow defect Histology or n Ajuvant therapy                                                                   involved lung 
   56 two stage r-middle, lower lobectomy 5.5cm Grade 3 3 non 
   58 one stage 1-S8 partial resection 5.5cm Grade 3R 4 Bleo 40Gy 
   71 two stage 1-S6 partial resection 11.0cm Grade 2 0 R40Gy 
   65 two stage 1-S6 partial resection 7.5cm Grade 2 0 R14Gy Bleo 
   72 two stage 1-S6 partial resection 8.0cm Grade 3R 4 R14Gy 
   56 one stage 1-upper lobectomy 4.5cm Grade 3 2 CDDP R40Gy 
r:right, l:left, R:preoperative irradiation
Fig. 1. Histology of Grade 1 showing involvement of the visceral 
pleura
Fig. 2. Histology of Grade 2 revealing preferable involvement of 
small bronchi and vessels
cancer infiltration preferable to the bronchial and vessel 
walls in the pulmonary parenchym. Grade 3: dense cancer 
infiltration to the lung regardless of the alveolar and the 
interstitial spaces. Although preoperative shadow defect 
ranged from 4.5cm to 11.0cm in length, a longer shadow 
defect was not proportional to the degree and the range of 
the involved lung. 
 Two out of 6 had no evidence of histologic cancer 
invasion to the lung. These received preoperative radiation 
of 14 Gy, and bleomycin was prescribed in one. It is not 
acertained as to whether involved lungs were benefited 
from irradiation therapy. Histologic finding revealed that 
Grade 3 was seen in 4, in which two received preoperative 
irradiation therapy. Grade 2 was indicated in 2. A n-
category was also histologically assessed. Two patients 
were categorized in n4, one in n3, one in n2 and the other 
two in no, the respectively. Preoperative irradiation therapy 
was done in 5, radiation dosis ranging from 40 Gy to 14 
Gy, and preoperative chemotherapy was bleomycin in two 
and CDDP in one, respectively. The operative procedure 
was subtotal esophagectomy in all in whom reconstruction 
was performed by the two staged operation in three. The 
operative procedures concurrently used were bilobectomy 
in one, lobectomy in one and partial resection in 4. As 
postoperative complications we have encountered respi-
ratory failure in one, heart failure in one and minor anasto-
motic insufficiency in 3. The two operative deaths, of heart 
failure and acute respiratory failure, were encountered on 
the first day and on the 12th day of surgery, respectively. 
The other 4 patients have expired of pneumonia in one and 
cancer recurrence in 3, at 4 to 7 months after surgery. 
  The surgical outcome was unsatisfactory. The reason for 
the unsatisfactory result remains obscure but main reasons 
are grave operative insult and far advanced carcinoma of 
the disease stages.
Fig. 3. Histology of Grade 3 illustrating a dense cancer infil-
tration regardless less of alveolar and interstitial spaces
dense fibous adhesion to carcinoma. Grade 1: cancer infil-
tration with the involved visceral pleura, scattering cancer 
invasion to alveolar walls and interstitial spaces. Grade 2:
Discussion 
In recent years, operative procedures for esophageal carci-
nomas have become more radical and extensive. A wide 
range of patients in terms of ages and underlying diseases 
have been subjected to surgical treatment. As the results, 
severe postoperative complications have been encountered. 
Many researches had clarified risk factors related to these 
complications, which included malnutrition (1), respiratory 
hypofunction (2), underlying diseases (3), and periop-
erative inadequate cares (4). The combined resection with 
involved lungs is now reasonably established and feasible 
in clinical use. On the other hand, it remains unsolved as to 
grave operative procedures leading to the acquired failure 
in host defense mechanisms (5, 6). A wide range of abnor-
malities in defense mechanisms contributes in part to 
operative mortality as well as enhancement of local recur-
rence and distant metastasis. These abnormalities of host
defensive mechanisms include deficiency in cell-mediated 
immunity and antibody-producing capacity and enhance-
ment in neutrophil cytocidal capacity and protease inhi-
bitors (1, 7, 8). 
  In determination of the surgical indication for advanced 
cancer-bearing patients, surgeons should be aware of 
tumor-related factors which cause protein-calorie malnu-
trition (PCM) and immunodeficiency (9). Needless to say, 
the patients requiring the combined resection with the lung 
have severely advanced carcinomas. Therefore, accurate 
assessment of preoperative patient's status is needed for 
determination of operative indication and selection of op-
erative procedures. Muller et al (10) reviewed 1201 reports 
on surgical treatment for esophageal carcinoma and they 
found that selection of patients and operative skill of sur-
geons are the key factors related to operative mortality 
(11). 
  As a result, the surgical outcome was not satisfactory as 
compared with that of conventional subtotal esopha-
gectomy. This is due to grave operative insult which is 
associated with a large amount of bleeding and requirement 
of massive blood transfusion needed at the combined resec-
tion with the lung and a wide nodal dissection. 
  Risks in perioperative care and treatment are in associ-
ation with pre-and post-operative nutritional and anticancer 
therapy (11). Attention should be paid for high mortality 
rates in relation to irradiation and anticancer drug infusion 
therapy prior, during and after surgery. In fact, attempts to 
prevent recurrence are fought with difficulty in applying 
for irradiation and anticancer drug infusion. Surgical tech-
niques are available for palliation of advanced cancer 
patients. However, avoidance of operative complications is 
not yet established, and poor knowledge on recurrence
prevention has made surgeons reluctant to prescribe pre-
ventive management, because host defense mechanism is 
impaired by itself in addition to surgical stress. The ulti-
mate goal in judging the effectiveness of ajuvant therapy 
requires more accumulation of experiences.
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